Market Analysis and Insights: Global Ibuprofen Market

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.

Due to the COVID-19 pandemic, the global Ibuprofen market size is estimated to be worth US$ 93 million in 2022 and is forecast to a readjusted size of US$ 112.3 million by 2029 with a CAGR of 2.7% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, USP accounting for % of the Ibuprofen global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Tablet segment is altered to an % CAGR throughout this forecast period.

Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, with about 81% market shares.

China is the largest supplier of Ibuprofen, with a production market share nearly 48%. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30%.

North America is the largest sales place, with a sales market share nearly 29%. Following North America, Europe is the second largest sales place with the sales market share of 26%.

The classification of Ibuprofen includes USP and EP and the sales proportion of USP Ibuprofen is about 65%.

Ibuprofen is applied in Tablet, Capsule, Suspension and Other. The most proportion of Ibuprofen is used in Tablet, and the market share is about 46%.

Global Ibuprofen Scope and Market Size

The global Ibuprofen market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


USP

EP


Segment by Application


Tablet

Capsule

Suspension

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Xinhua Pharmaceutical

IOLCP

Granules Biocause

Strides Shasun

BASF

SI Group

Xinhua-Perrigo Pharmaceutical

Hisoar